Pages that link to "Q34689934"
Jump to navigation
Jump to search
The following pages link to A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery (Q34689934):
Displaying 50 items.
- Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Q24632872) (← links)
- Administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention (Q26748752) (← links)
- Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review (Q26992262) (← links)
- Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery (Q28072799) (← links)
- Low molecular weight heparin and unfractionated heparin in the early pharmacologic management of acute coronary syndromes: a meta-analysis of randomized clinical trials (Q28192889) (← links)
- DVT prophylaxis and anticoagulation in the surgical patient (Q28194897) (← links)
- Clinical application of enoxaparin (Q33360866) (← links)
- Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy (Q33360869) (← links)
- Low Molecular Weight Heparins: An Emerging New Class of Glycosaminoglycan Antithrombotics (Q33370169) (← links)
- Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin (Q33370626) (← links)
- Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement (Q33393874) (← links)
- An evaluation of the biological response to Fraxiparine, (a low molecular weight heparin) in the healthy individual (Q33395878) (← links)
- Contemporary use of and future roles for heparin in antithrombotic therapy (Q33495687) (← links)
- Prevention and treatment of venous thromboembolism (Q33496843) (← links)
- New thrombolytics, anticoagulants, and platelet antagonists: the future of clinical practice (Q33655209) (← links)
- Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange. (Q33685447) (← links)
- Benefits of novel oral anticoagulant agents for thromboprophylaxis after total hip or knee arthroplasty (Q33714792) (← links)
- Deep vein thrombosis and pulmonary embolism prophylaxis in joint replacement surgery (Q33722894) (← links)
- New-generation anticoagulants: the low molecular weight heparins (Q33781946) (← links)
- Formulary management of low molecular weight heparins (Q33881653) (← links)
- Low molecular weight heparin in acute coronary syndromes (Q34027303) (← links)
- Low-molecular-weight heparin prophylaxis: preoperative versus postoperative initiation in patients undergoing elective hip surgery (Q34244277) (← links)
- Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis (Q34322366) (← links)
- Radiology interventions in patients receiving low molecular weight heparin: timing is critical (Q34352619) (← links)
- Low-Molecular-Weight Heparins (Q34437479) (← links)
- Low molecular weight heparin in prevention of perioperative thrombosis (Q34534567) (← links)
- Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis (Q34592750) (← links)
- Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement (Q34708293) (← links)
- Glycosaminoglycans in Prophylaxis Against Venous Thromboembolism (Q35150857) (← links)
- Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery (Q35160253) (← links)
- Prevention of venous thromboembolism after surgery: A review of enoxaparin (Q35229348) (← links)
- Low molecular weight heparins. An objective overview (Q35233595) (← links)
- Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism (Q35567223) (← links)
- Anticoagulant drugs in the elderly: valuable in selected patients (Q35704478) (← links)
- Total joint replacement of the hip and knee. (Q35796189) (← links)
- Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected]. (Q35851245) (← links)
- Incidence of venous thromboembolism using 64 channel multidetector row computed tomography-indirect venography and anti-coagulation therapy after total knee arthroplasty in Korea (Q35926975) (← links)
- Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study (Q36131612) (← links)
- The principles and practice of anticoagulant therapy (Q36414660) (← links)
- 2 Mechanisms of action of low molecular weight heparins and heparinoids (Q36618545) (← links)
- The impact of inherited thrombophilia on surgery: a factor to consider before transplantation? (Q37179099) (← links)
- Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis (Q37180937) (← links)
- The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force (Q37232098) (← links)
- Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations (Q37472172) (← links)
- Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins (Q37568164) (← links)
- Prophylaxis of venous thromboembolism (Q37827836) (← links)
- Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance (Q37828252) (← links)
- Enoxaparin: a pharmacologic and clinical review (Q37862264) (← links)
- Prevention of VTE Following Total Hip and Knee Arthroplasty in Hemophilia Patients (Q37873425) (← links)
- Prophylaxis for deep vein thrombosis and pulmonary embolism in the geriatric patient undergoing surgery. (Q37944582) (← links)